Picture of Morgan Stanley logo

MS Morgan Stanley News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsBalancedLarge CapNeutral

REG - Morgan Stanley&CoLLC - Rule 38.5 - ABBVIE INC.




 



RNS Number : 2691G
Morgan Stanley & Co. LLC
16 March 2020
 

 

 FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley & Co. LLC

 Company dealt in

   ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

   13 MARCH 2020

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  2,234,895

 86.3000 USD

 80.4900 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  2,346,851

 86.3050 USD

 80.4900 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

 N/A

 N/A

 N/A

 N/A

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 CALL

 PURCHASE

 100

 97.5000

A

 20/03/2020

 0.1400 USD

 CALL

 PURCHASE

 500

 95.0000

A

 20/03/2020

 0.1600 USD

 CALL

 PURCHASE

 400

 100.0000

A

 15/05/2020

 1.0500 USD

 CALL

 PURCHASE

 200

 100.0000

A

 15/05/2020

 1.3600 USD

 CALL

 PURCHASE

 500

 85.0000

A

 20/03/2020

 1.7500 USD

 CALL

 PURCHASE

 100

 95.0000

A

 15/05/2020

 1.9700 USD

 CALL

 PURCHASE

 100

 95.0000

A

 15/05/2020

 1.9700 USD

 CALL

 PURCHASE

 100

 95.0000

A

 15/05/2020

 2.4000 USD

 CALL

 PURCHASE

 100

 95.0000

A

 15/05/2020

 2.5600 USD

 CALL

 PURCHASE

 100

 90.0000

A

 17/04/2020

 3.1500 USD

 PUT

 PURCHASE

 100

 82.0000

A

 27/03/2020

 3.3400 USD

 CALL

 PURCHASE

 100

 92.5000

A

 19/06/2020

 3.4500 USD

 CALL

 PURCHASE

 100

 84.5000

A

 27/03/2020

 3.4600 USD

 CALL

 PURCHASE

 100

 87.5000

A

 17/04/2020

 3.6900 USD

 CALL

 PURCHASE

 100

 90.0000

A

 15/05/2020

 3.8400 USD

 CALL

 PURCHASE

 100

 85.0000

A

 17/04/2020

 4.9000 USD

 CALL

 PURCHASE

 100

 95.0000

A

 15/01/2021

 5.2900 USD

 CALL

 PURCHASE

 500

 82.5000

A

 15/05/2020

 6.5100 USD

 CALL

 PURCHASE

 100

 80.0000

A

 03/04/2020

 7.0200 USD

 CALL

 PURCHASE

 100

 80.0000

A

 18/09/2020

 9.0500 USD

 CALL

 PURCHASE

 300

 70.0000

A

 21/08/2020

 17.0000 USD

 CALL

 SALE

 100

 90.0000

A

 13/03/2020

 0.0100 USD

 CALL

 SALE

 200

 91.5000

A

 13/03/2020

 0.0100 USD

 CALL

 SALE

 200

 91.5000

A

 13/03/2020

 0.0100 USD

 CALL

 SALE

 200

 100.0000

A

 20/03/2020

 0.0800 USD

 CALL

 SALE

 200

 100.0000

A

 20/03/2020

 0.0800 USD

 CALL

 SALE

 100

 100.0000

A

 20/03/2020

 0.0800 USD

 CALL

 SALE

 100

 85.5000

A

 13/03/2020

 1.0600 USD

 CALL

 SALE

 100

 92.0000

A

 27/03/2020

 1.2300 USD

 CALL

 SALE

 100

 110.0000

A

 15/01/2021

 2.4500 USD

 CALL

 SALE

 500

 110.0000

A

 15/01/2021

 2.4500 USD

 PUT

 SALE

 500

 84.0000

A

 20/03/2020

 3.7600 USD

 PUT

 SALE

 100

 60.0000

A

 15/01/2021

 4.6300 USD

 PUT

 SALE

 500

 75.0000

A

 19/06/2020

 5.8900 USD

 PUT

 SALE

 500

 75.0000

A

 19/06/2020

 5.8900 USD

 PUT

 SALE

 600

 85.0000

A

 03/04/2020

 5.9400 USD

 CALL

 SALE

 100

 87.5000

A

 19/06/2020

 6.0200 USD

 CALL

 SALE

 100

 90.0000

A

 18/09/2020

 6.3400 USD

 CALL

 SALE

 100

 85.0000

A

 19/06/2020

 7.1500 USD

 PUT

 SALE

 100

 70.0000

A

 15/01/2021

 7.8900 USD

 PUT

 SALE

 100

 70.0000

A

 15/01/2021

 7.8900 USD

 PUT

 SALE

 100

 70.0000

A

 15/01/2021

 7.8900 USD

 CALL

 SALE

 2,000

 80.0000

A

 17/04/2020

 7.9400 USD

 PUT

 SALE

 200

 70.0000

A

 15/01/2021

 8.0100 USD

 CALL

 SALE

 100

 85.0000

A

 15/01/2021

 9.0500 USD

 CALL

 SALE

 100

 85.0000

A

 15/01/2021

 9.0500 USD

 PUT

 SALE

 200

 80.0000

A

 15/01/2021

 11.1900 USD

 PUT

 SALE

 200

 80.0000

A

 15/01/2021

 11.1900 USD

 PUT

 SALE

 100

 94.0000

A

 03/04/2020

 13.7800 USD

 PUT

 SALE

 500

 90.0000

A

 15/01/2021

 18.3600 USD

 CALL

 SALE

 300

 65.0000

A

 21/08/2020

 20.8000 USD

 PUT

 SALE

 100

 110.0000

A

 21/08/2020

 32.1200 USD

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 CALL

 100

 76.5000 USD

 CALL

 500

 81.5000 USD

 CALL

 100

 82.5000 USD

 CALL

 400

 84.5000 USD

 PUT

 1,800

 87.0000 USD

 PUT

 1,200

 88.0000 USD

 CALL

 1,100

 83.0000 USD

 PUT

 11,000

 85.5000 USD

 PUT

 300

 88.5000 USD

 PUT

 1,300

 93.0000 USD

 PUT

 100

 94.0000 USD

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 16 MARCH 2020

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISESFEFSMESSEID

Recent news on Morgan Stanley

See all news